Biosimilars haven’t always yielded lower out-of-pocket costs for patients, study finds
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
AUA 2024 advanced kidney cancer, synchronous metastatic renal cell carcinoma (mRCC), cytoreductive nephrectomy, metastatic burden reduction.
Sam Chang engages with Josh Meeks to discuss nadofaragene firadenovec’s role in treating BCG-unresponsive bladder cancer. They consider the significance of clinical trials and FDA…
Financial strain is created by inequitable health financing structures that overpay private academic medical centers at the expense of safety net hospitals.
AUA 2024, metatatic renal cell carcinoma (mRCC), Sarcomatoid Features in mRCC, metastatic sarcomatoid renal cell carcinoma (msRCC), Cytoreductive Nephrectomy, Immune Checkpoint Inhibitors (ICI), ipilimumab, nivolumab,…
AUA 2024 telemedicine in urology, use of telehealth could reduce racial and ethnic disparities in prostate cancer care, National Health Interview Survey, prostate cancer.
AUA 2024 non-invasive bladder cancer, phase 1 study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11, non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
AUA 2024 prostate cancer detection and screening, results of a comparative analysis of clinician performance versus magnetic resonance imaging (MRI), ultrasound integration for artificial intelligence-based…
A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from
AUA 2024 prostate cancer detection and screening, characteristics of PIRADS 5 lesions in men with a negative or Grade Group 1 biopsy, Prostate Imaging Reporting…
AUA 2024 prostate cancer detection and screening, midlife baseline PSA as a predictor of lethal prostate cancer between Black and White men, prostate cancer mortality.